RESUMEN
We present the case of a 30 year old woman with HIV/AIDS who experienced a 47 percent weight gain over a period of a year after commencing treatment with highly active anti-retroviral therapy (HAART) and went on to develop benign intracranial hypertension (BIH). She was not on any other medication associated with BIH. Although weight gain has been reported in patients on treatment with protease inhibitors, such gains have been minimal to moderate. We are unaware of any previous report of this degree of weight gain or BIH in a patient on protease inhibitors.(Au)
Asunto(s)
Adulto , Informes de Casos , Femenino , Humanos , Seudotumor Cerebral/inducido químicamente , Aumento de Peso/efectos de los fármacos , Terapia Antirretroviral Altamente Activa/efectos adversos , Síndrome de Inmunodeficiencia Adquirida/tratamiento farmacológico , Seudotumor Cerebral/inducido químicamenteRESUMEN
We present the case of a 30-year-old woman with HIV/AIDS who experienced a 47 weight gain over a period of a year after commencing treatment with highly active anti-retroviral therapy (HAART) and went on to develop benign intracranial hypertension (BIH). She was not on any other medication associated with BIH. Although weight gain has been reported in patients on treatment with protease inhibitors, such gains have been minimal to moderate. We are unaware of any previous report of this degree of weight gain or BIH in a patient on protease inhibitors.
Asunto(s)
Humanos , Femenino , Adulto , Seudotumor Cerebral , Aumento de Peso , Terapia Antirretroviral Altamente Activa , Seudotumor Cerebral , Síndrome de Inmunodeficiencia Adquirida/tratamiento farmacológicoRESUMEN
We present the case of a 30-year-old woman with HIV/AIDS who experienced a 47% weight gain over a period of a year after commencing treatment with highly active anti-retroviral therapy (HAART) and went on to develop benign intracranial hypertension (BIH). She was not on any other medication associated with BIH. Although weight gain has been reported in patients on treatment with protease inhibitors, such gains have been minimal to moderate. We are unaware of any previous report of this degree of weight gain or BIH in a patient on protease inhibitors.